Bactericidal and Anti-biofilm Activity of the Retinoid Compound CD437 Against Enterococcus faecalis

Area of Science:

• Microbiology
• Drug Discovery
• Infectious Diseases

Background:

• Enterococcus faecalis is a significant cause of hospital-acquired infections.
• Antibiotic resistance in enterococci is a growing global health concern.
• Novel antibacterial agents are critically needed to address this challenge.

Purpose of the Study:

• To evaluate the antibacterial and anti-biofilm potential of the synthetic retinoid compound CD437.
• To investigate the efficacy of CD437 against Enterococcus faecalis and Staphylococcus species.
• To explore the effects of CD437 on biofilm formation and mature biofilms.

Main Methods:

• In vitro assessment of CD437's bactericidal activity against E. faecalis.
• Evaluation of CD437 in combination with existing antibiotics (gentamicin, ceftriaxone sodium).
• Analysis of CD437's impact on biofilm formation and mature biofilms of E. faecalis and Staphylococcus species.

Main Results:

• CD437 demonstrated potent bactericidal effects against Enterococcus faecalis.
• Synergistic effects were observed when CD437 was combined with gentamicin.
• CD437 effectively inhibited E. faecalis biofilm formation and eradicated mature biofilms.
• Antibacterial and anti-biofilm activity was also noted against Staphylococcus species.
• CD437 reduced Pseudomonas aeruginosa biofilm matrix formation, though it lacked direct bactericidal action.

Conclusions:

• The synthetic retinoid CD437 exhibits significant potential as a novel antibacterial agent.
• CD437 demonstrates efficacy against Gram-positive bacteria and their biofilms.
• Further development of CD437 could offer a new therapeutic option against resistant pathogens.